
- S6 Kinase Substrate Peptide 32
- CMK
- BIX 02565
- BI-D1870
- PF-4708671
FMKRSK inhibitor |
Sample solution is provided at 25 µL, 10mM.
































Quality Control & MSDS
- View current batch:
- Purity = 98.13%
- COA (Certificate Of Analysis)
- HPLC
- NMR (Nuclear Magnetic Resonance)
- MSDS (Material Safety Data Sheet)
- Datasheet
Chemical structure

Description | FMK is a potent, highly specific and irreversible inhibitor of p90 ribosomal protein S6 kinase RSK1 and RSK2. | |||||
Targets | RSK1 | RSK2 | ||||
IC50 | 15 nM |
Cell experiment [1]: | |
Cell lines | Ba/F3 cells, FGFR3-expressing myeloma cell lines KMS11 |
Preparation method | The solubility of this compound in DMSO is >17.1mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37 ℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
Reacting condition | 0.5-10 μM, 16 and 24 hr |
Applications | FMK effectively inhibited FGFR3 TDII and TEL-FGFR3-induced IL-3-independent growth of Ba/F3 cells in a dose-dependent manner. RSK inhibitor fmk inhibits cytokine-independent proliferation of Ba/F3 cells conferred by FGFR3. Fmk induced significant apoptosis in fgfr3-expressing, t(4;14)-positive human myeloma cell lines and primary human myeloma cells. |
Other notes | Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
References: [1]. Kang S, Dong S, Gu T L, et al. FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway[J]. Cancer cell, 2007, 12(3): 201-214. |

FMK Dilution Calculator
calculate

FMK Molarity Calculator
calculate
Cas No. | 821794-92-7 | SDF | Download SDF |
Synonyms | fluoromethylketone-pyrrolopyrimidine scaffold | ||
Chemical Name | 1-[4-amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethanone | ||
Canonical SMILES | CC1=CC=C(C=C1)C2=C(N(C3=C2C(=NC=N3)N)CCCO)C(=O)CF | ||
Formula | C18H19FN4O2 | M.Wt | 342.37 |
Solubility | ≥17.1 mg/mL in DMSO, ≥28.7 mg/mL in EtOH, <1.74 mg/ml="" in="" h2o="">1.74> | Storage | Store at -20°C |
Physical Appearance | A solid | Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. |
FMK is a potent, highly specific and irreversible ribosomal s6 kinase (RSK) inhibitor with IC50 value of 15 nM.[1]RSK is named for ribosomal protein s6, part of the translational machinery which are serine/threonine kinases and are activated by the MAPK/ERK pathway. There are two subfamilies of RSK, p90rsk, also known as MAPK-activated protein kinase-1 (MAPKAP-K1), and p70rsk, also known as S6-H1 Kinase or simply S6 Kinase.90 kDa ribosomal S6 kinases(p90rsk),the first substrates of ERK,is a ubiquitous and versatile mediator of ERK signal transduction which regulates protein synthesis by phosphorylation of polyribosomal proteins and glycogen synthase kinase-3 and phosphorylates the Ras GTP/GDP-exchange factor, leading to feedback inhibition of the Ras-ERK pathway.[2]FMK is an irreversible inhibitor that covalently modifies the C-terminal kinase domain of RSK. It therefore prevents the activation of the N-terminal kinase domain of RSK by the C-terminal kinase domain, but does not affect the activity of the N-terminal domain, explaining why the active forms of RSK1 and RSK2 are not inhibited by FMK in vitro.[3] FMK,the efficacy and specificity of the irreversible RSK inhibitor in ARVMs and subsequently is used to determine the role of RSK as a direct regulator of NHE1 phosphorylation and sarcolemmal NHE activity in this cell type, in response to 1-adrenergic stimulation.[4] FMK-pa, a propargylamine variant, achieves selective and saturable modification of endogenous RSK1 and RSK2 in mammalian cells. Saturating concentrations of fmk-pa inhibited Ser386 phosphorylation and downstream signaling in response to phorbol ester stimulation, but had no effect on RSK activation by lipopolysaccharide.[5]Metastasis, the spreading of cancer cells from a primary tumor to secondary sites throughout the body, is driven by altered signaling pathways that induce changes in cell-cell adhesion, the cytoskeleton, integrin function, protease expression, epithelial-to-mesenchymal transition and cell survival.[6] The ribosomal S6 kinase (RSK) family of kinases is a group of extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) effectors that can regulate these steps of metastasis by phosphorylating both nuclear and cytoplasmic targets. Thus, developing RSK inhibitors as new antimetastasis drugs is urgent.Recently, RSKs have been shown to mediate many cellular functions critical for cancer progression. RSK may be an important driver in PCa progression in bone which regulates anchorage-independent growth through transcriptional regulation of factors that modulate cell survival, including ING3, CKAP2 and PTK6,resulting in promising potential as a therapeutic target for PCa bone metastasis.[7]Reference:1.Michael S. Cohen. et al. Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors. Science,2005,308(5726):1318-1321.2.Frodin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol. 1999, 151(1-2):65-77.3.Jenny BAIN.et al. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315.4.Cuello F.et al. Evidence for direct regulation of myocardial Na+/H+ exchanger isoform 1 phosphorylation and activity by 90-kDa ribosomal S6 kinase (RSK): effects of the novel and specific RSK inhibitor fmk on responses to alpha1-adrenergic stimulation. Mol Pharmacol. 2007, 71(3):799-806.5.Michael S Cohen, Haralambos Hadjivassiliou1, and Jack Taunton. A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. Nat Chem Biol. 2007,3(3): 156-160. 6.Sulzmaier FJ1, Ramos JW. RSK isoforms in cancer cell invasion and metastasis.Cancer Res. 2013,73(20):6099-105.7.Yu G, Lee YC1. et al. RSK Promotes Prostate Cancer Progression in Bone through ING3, CKAP2 and PTK6-mediated Cell Survival. Mol Cancer Res.2014,0384.
ebiomall.com






>
>
>
>
>
>
>
>
>
>
>
过完年,再开培养箱参数不稳定,两个箱子,co2数值一直在闪~我要养细胞,参数设置的是37℃,5%CO2,请问各位大神有知道咋回事的~还有面板上各种符号啥意思?图中标记的都是在闪的参数
光照培养箱具有超温和传感器异常保护功能,保障仪器和样品安全;选配全光谱的植物生长灯,有利于植物的生长,提高抗病性。具有掉电记忆、掉电时间自动补偿功能;恒温控制系统,反应快,控温精度高。 用途:微电脑全自动控制,触摸开关,操作简便;可编程多段控制方式,白天、黑夜均可单独设置温度、湿度、光照度和时间等。风道式通风,工作室风速柔和,温度均匀;中空反射钢化渡膜玻璃,绝热性能好,美观大方。全封闭不透光灯罩,选装工作室电源,消毒装置等。我们购买的是喆图的光照培养箱,服务质量都不错,推荐下
适用于环境保护、卫生防疫、药检、农畜、水产等科研、院校和生产部门。是水体分析和BOD测定,细菌、霉菌、微生物的培养、保存、植物栽培、育种试验的专用恒温设备。
产品特点
1.带定时功能键的数显微电脑温度控制器,控温精确可靠;
2.采用镜面不锈钢内胆,半圆弧四角易清洁,箱内搁板间距可调;
3.采用玻璃观察窗,观察方便明了;
4.设有独立限温报警系统,超过限制温度即自动中断,保证实验安全运行,不发生意外;
Hi.baidu/=。www.jingda17.net。DI
B)防止皿盖上冷凝水滴到正在生长的菌落上而将其冲散,影响微生物生长;且不易辨别菌落特征、不便计数。
C)防止杂菌污染
D)由于重力的作用使培养基表面及次层能富集微生物生长所需的营养物质,利于微生物生长。
仅供您参考:)

